A long-term assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis

Journal of Dermatological Treatment

Volumn 7, Issue SUPPL. 1, 1996, Pages

  Van de Kerkhof, P C M ^a   Van Harten, J ^b   Verjans, H ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Bio R and D   (Netherlands)

Author keywords

Calcitriol; Psoriasis; Vitamin D

Indexed keywords

ANTIPSORIASIS AGENT; CALCITRIOL; CALCIUM ION; PHOSPHORUS;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERCALCEMIA; LABORATORY TEST; LONG TERM CARE; MULTICENTER STUDY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PSORIASIS; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

EID: 0029800219     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639609080597     Document Type: Article

References (16)

1. Kragballe K, Tore Giertzen B, de Hoop D et al, Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet (1991) 337: 193-6.
2. Ramsay CA, Long term efficacy and safety of calcipotriol in the treatment of psoriasis vulgaris. (Abstract) 2nd International Symposium on Calcipotriol, Monte Carlo, Monaco, France 1993.
3. Smith AL, Pincus SH, Donovan L et al, A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol (1988) 19: 516-28.
4. 3 ointment. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D. Gene regulation, structure-function analysis and clinical application. Walter de Gruyter: Berlin, 1991, pp 430-1.
5. 3 calcitriol ointment in psoriasis. J Dermatol Treat (1992) 3: 177-84.
6. Langner A, Verjans H, Stapór V et al, Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study. Br J Dermatol (1993) 128: 566-71.
7. 3 analogue, 1α,24 (R)-dihydroxycholecalciferol. Br J Dermatol (1986) 115: 431-3.
8. TV-02 Ointment Research Group, A placebo-controlled double blind right/left comparison study on the efficacy of the TV-02 ointment for the treatment of psoriasis. Nishinihon J Dermatol (1991) 53: 1252-61.
9. 3 for the treatment of psoriasis. Eur J Dermatol (1993) 2: 255-61.
10. TV-02 Ointment Research Group, Double blind, right/left comparison of TV-02 ointment and betamethasone valerate in treatment of psoriasis. Nishinihon J Dermatol (1989) 51: 963-9.
11. TV-02 Ointment Research Group. Assessment of the safety of TV ointment for patients with psoriasis. Nishinihon J Dermatol (1989) 51: 317-24.
12. 3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol (1994) 131: 57-63.
13. Fredriksson T, Lassus A, Salde L, Reproducibility of clinical trials of topical glucocorticosteroids. Int J Dermatol (1983) 22: 536-9.
14. Rajka G, Verjans HL, Hydrocortisone 17-butyrate (Locoid®) 0.1% fatty cream versus desonide (Apolar®) 0.1% ointment in the treatment of patients suffering from atopic dermatitis. J Int Med Res (1986) 14: 85-90.
15. Lasthein Andersen B, Ejner Andersen K, Nielsen R et al, Treatment of dry atopic dermatitis in children. A double-blind comparison between Mildison Lipocream® (1% hydrocostisone) and Uniderm® (1% hydrocortisone) ointment. Clin Trials J (1988) 25: 278-84.
16. Fredriksson T, Pettersson U, Severe psoriasis - oral therapy with a new retinoid. Dermatologica (1978) 157: 1238-44.